Yamane H - Search Results

1

Targeting ROR1 in combination with osimertinib in EGFR mutant lung cancer cells.

Nakagawa N, Miyake N, Ochi N, Yamane H, Takeyama M, Nagasaki Y, Ikeda T, Yokota E, Fukazawa T, Nakanishi H, Harada D, Kiura K, Takigawa N. Nakagawa N, et al. Among authors: yamane h. Exp Cell Res. 2021 Dec 15;409(2):112940. doi: 10.1016/j.yexcr.2021.112940. Epub 2021 Nov 19. Exp Cell Res. 2021. PMID: 34808132

2

[Chemotherapy for small-cell lung cancer].

Ueoka H, Kiura K, Tabata M, Bessho A, Matsushita A, Chikamori K, Yamane H, Harada M, Kimura I, Ohnoshi T. Ueoka H, et al. Among authors: yamane h. Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Dec;34 Suppl:87-91. Nihon Kyobu Shikkan Gakkai Zasshi. 1996. PMID: 9216192 Review. Japanese.

3

Direct intracerebral invasion from skull metastasis of large cell lung cancer.

Hiraki A, Tabata M, Ueoka H, Kiura K, Shibayama T, Yamane H, Harada M. Hiraki A, et al. Among authors: yamane h. Intern Med. 1997 Oct;36(10):720-3. doi: 10.2169/internalmedicine.36.720. Intern Med. 1997. PMID: 9372335 Free article.

4

Small cell lung cancer can express CD34 antigen.

Yamane H, Kiura K, Tabata M, Bessho A, Tsuchida T, Motoda K, Hiraki A, Ueoka H, Harada M. Yamane H, et al. Anticancer Res. 1997 Sep-Oct;17(5A):3627-32. Anticancer Res. 1997. PMID: 9413215

5

Spontaneous biloma as a complication of small cell lung cancer.

Hiraki A, Ueoka H, Tabata M, Kiura K, Bessho A, Yamane H, Nogami N, Harada M. Hiraki A, et al. Among authors: yamane h. Lung Cancer. 1998 Feb;19(2):127-30. doi: 10.1016/s0169-5002(97)00077-9. Lung Cancer. 1998. PMID: 9567249

6

An alteration of ganglioside composition in cisplatin-resistant lung cancer cell line.

Kiura K, Watarai S, Ueoka H, Tabata M, Gemba K, Aoe K, Yamane H, Yasuda T, Harada M. Kiura K, et al. Among authors: yamane h. Anticancer Res. 1998 Jul-Aug;18(4C):2957-60. Anticancer Res. 1998. PMID: 9713491

7

Loss of HLA haplotype in lung cancer cell lines: implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer.

Hiraki A, Kaneshige T, Kiura K, Ueoka H, Yamane H, Tanaka M, Harada M. Hiraki A, et al. Among authors: yamane h. Clin Cancer Res. 1999 Apr;5(4):933-6. Clin Cancer Res. 1999. PMID: 10213231

8

High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.

Bessho A, Ueoka H, Kiura K, Tabata M, Sunami K, Katayama Y, Yamane H, Hiraki A, Harada M. Bessho A, et al. Among authors: yamane h. Anticancer Res. 1999 Jan-Feb;19(1B):693-8. Anticancer Res. 1999. PMID: 10216478 Clinical Trial.

9

Double high-dose chemotherapy supported by autologous transplantation of peripheral blood stem cells for treatment of an elderly patient with small-cell lung cancer.

Yamane H, Bessho A, Kiura K, Tabata M, Katayama Y, Motoda K, Tsuchida T, Nogami N, Hiraki A, Ueoka H, Harada M. Yamane H, et al. Intern Med. 1999 Nov;38(11):892-5. doi: 10.2169/internalmedicine.38.892. Intern Med. 1999. PMID: 10563752 Free article.

10

Interleukin-12 augments cytolytic activity of peripheral blood mononuclear cells against autologous lung cancer cells in combination with IL-2.

Hiraki A, Kiura K, Yamane H, Nogami N, Tabata M, Takigawa N, Ueoka H, Tanimoto M, Harada M. Hiraki A, et al. Among authors: yamane h. Lung Cancer. 2002 Mar;35(3):329-33. doi: 10.1016/s0169-5002(01)00424-x. Lung Cancer. 2002. PMID: 11844609

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

822 results

Search Page